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Abstract 
Purpose: Bowel motion is a source of artifacts in mouse abdominal MRI. The use of fasting and 
hyoscine butylbromide (BUSC) for the purpose of bowel motion reduction has been inconsistently 
reported, without a thorough assessment of efficacy. This work aimed to better evaluate these 
methods in the mouse with high-field MRI. 
Methods: Thirty-two adult C57BL/6 mice were imaged in a pre-clinical 9.4T MR scanner. A 
FLASH sequence with 284 repetitions was used, lasting 90 minutes, with a ~19s temporal 
resolution. Eight mice were injected with a high-dose and eight mice with a low-dose bolus of 
BUSC. Eight mice were food deprived for 4.5-6.5 hours and another group of 8 mice were injected 
with saline. Two readers reviewed the images and classified the magnitude of bowel motion 
during each scan. Also, the sum of the absolute differences between consecutive images was 
calculated for 10-11 min intervals throughout the acquisition and mapped voxelwise for 
identification of moving regions. After defining the most effective protocol, high-resolution T2-
weighted and diffusion-weighted images were acquired to demonstrate its applicability. 
Results: High-dose BUSC was the most effective protocol for bowel motion reduction, for up to 
45 min. Fasting and saline effects were negligible. The high-resolution images clearly 
demonstrate BUSC effectiveness in abdominal MRI. 
Conclusion: These data favor the use of BUSC for abdominal MRI in the mouse, when bowel 
motion reduction is desired, taking into account the estimated time interval from injection to start 
of bowel motion reduction (~8.5 minutes) and duration of effect (~45 minutes). 
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Introduction 
Abdominal MRI in the in vivo mouse is frequently hindered by physiological motion such as 
breathing and bowel motility, which cause blurring and ghosting artifacts(1). Several techniques 
are widely used for respiratory motion compensation with relatively satisfactory results, such as 
breathing rate triggered sequences or by placing animals in the supine position(2–4). However, 
despite the importance of suppressing bowel motion, there is little consensus on how to achieve 
it in the mouse(4–7). Fasting and hyoscine butylbromide (BUSC), trademarked Buscopan®, are 
the most commonly used methods, but their efficacy has not yet been thoroughly assessed. Food 
deprivation of at least 4 hours was reported to decrease peristalsis due to the absence of digestion 
and gut relaxation(4,7). BUSC, on the other hand, is a spasmolytic agent routinely used in the 
clinical setting to reduce motion artifacts from intestinal peristaltic movements(8–12). In the 
mouse, however, there is not a consensus on the best dosage to apply, with proposed values 
varying in several orders of magnitude(4–6). Furthermore, the motion reduction window with 
BUSC is reportedly short (≈ 5-10 minutes)(4,6). Clearly, suppressing bowel motion over longer 
periods can be imperative for high-quality abdominal MRI. The aim of this study was thus to 
develop a consistent protocol for bowel-motion reduction in the mouse and evaluate its 
performance. To achieve that, we tested a food deprivation protocol against two different (high- 
and low-dose) BUSC protocols reported in the literature(4,6) and estimated the resulting amount 
of motion suppression in a 90 min period by acquiring MR images of the abdomen at 9.4 T with a 
temporal resolution of approximately 19 s. Moreover, we acquired high resolution T2-weighted 
and diffusion-weighted MR images of the entire abdomen before and after the most effective 
BUSC protocol administration, demonstrating its applicability for studies that require sharp 
definition of the bowel or parenchymal organs such as the liver, pancreas, spleen and kidneys, 
especially when high resolution images are acquired. 
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Methods 
All animal experiments were carried out according to the European Directive 2010/63 and 
preapproved by the Institution’s Review Board and the national competent authority. An 
abbreviated study fluxogram is presented in Figure 1. 
 
Animal preparation 
Thirty-six wild-type male mice on a C57BL/6J background weighing 27.8 ± 2.3 g and aged 14.8 ± 
4.6 weeks were used in this study. Animals were reared in a temperature-controlled room and 
held under a 12h/12h light/dark regimen with ad libitum access to food and water. 
Anesthesia was induced with 5% isoflurane (VetfluraneTM, Virbac, France) mixed with oxygen-
enriched (28%) air in a custom-built plastic box. Mice were then weighted, moved to the animal 
bed (Bruker BioSpinTM, Germany) and isoflurane dose was lowered to 2-3%. The respiratory rate 
and temperature were monitored and kept stable throughout the experiment using a respiration 
pillow sensor and an optic fiber rectal temperature probe (both SA Instruments Inc., Stony Brook, 
USA), respectively. Body temperature was controlled with a warm-water circulating pad and 
ophthalmic gel (Vidisic® Gel, Bausch+Lomb, Canada) was applied to prevent eye dryness. 
A 24G x ¾" catheter was inserted intraperitoneally in N = 28 animals for BUSC or saline 
administration. All injections were performed using a syringe pump (GenieTouchTM, Kent 
Scientific, Torrington, Connecticut, USA). 
 
MRI hardware and initial adjustments 
Animals were imaged in a 9.4T BioSpec® MRI scanner (Bruker, Karlsruhe, Germany) equipped 
with an AVANCETM III HD console including a gradient unit capable of producing pulsed field 
gradients of up to 660 mT/m isotropically with a 120 μs rise time. RF transmission and reception 
were achieved using a 40 mm-ID linear transmit-receive volume coil (Bruker, Karlsruhe, 
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Germany). All scanning sessions began with localizer scans ensuring the optimal positioning of 
the animal and routine adjustments for center frequency, RF calibration, acquisition of B0 maps 
and automatic shimming. 
 
Temporal characterization of bowel motion reduction protocols 
MRI protocol 
Two 1-mm thick coronal slices were positioned in the abdomen and a FLASH sequence (TR/TE 
= 19/2 ms, flip angle = 20, FOV = 25 x 25 mm2, in-plane resolution = 120 x 120 µm2, respiratory 
triggering) was acquired for 284 repetitions in a total duration of approximately 90 min (temporal 
resolution ≈ 19 s) in N = 32 animals. 
 
Bowel motion reduction protocols 
Mice were divided into four groups: 8 animals (16.5 ± 2.1 weeks old, 28.7 ± 1.3 g) were food 
deprived between 4 h 30 min to 6 h 30 min prior to the experiment; 8 animals (15.3 ± 3.1 weeks 
old, 28.1 ± 1.9 g) were injected with a bolus of 0.5 mg/kg(4) BUSC (5 µL/g of BUSC solution 
(Buscopan® 20 mg/ml, Boehringer Ingelheim, Barcelona, Spain) diluted 1:200 in saline) after 10 
min of acquisition – low-dose BUSC group; 8 animals (12.4 ± 4.2 weeks old, 27.9 ± 3.8 g) were 
injected with a bolus of 5 mg/kg(6)  BUSC (5 µL/g of 20 mg/ml BUSC solution diluted 1:20 in 
saline) after 10 min of acquisition – high-dose BUSC group; and, as a control, 8 animals (12.7 ± 
6.0 weeks old, 26.5 ± 0.8 g) were injected with 5 µL/g of saline after 10 min of acquisition. In the 
end, all mice recovered from sedation within a few minutes. 
 
Data analysis 
The data analysis included two main parts: a qualitative analysis of the images performed by two 
readers in order to define periods with strong bowel motion reduction, and a quantitative analysis 
of the data to produce motion maps and time-courses for each animal. 
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i. Individual definition and classification of relevant timings 
Two gastrointestinal radiologists (with 7 years and 9 years’ experience) reviewed the acquired 
images, blinded to the interventions performed on the animals, and separately divided each slice 
time-course into time blocks with different amounts of peristaltic motion. A classification between 
1 and 3 was qualitatively assigned to each block according to the degree of motion: 1 - if peristalsis 
was strongly reduced, 2 - if peristalsis was partly reduced but with residual movement of bowel 
content, and 3 - if there was a maintained peristalsis (Figure 2). Blocks with a classification of 1 
and 2 were then merged to define periods with overall motion reduction and therefore obtain, 
whenever possible, two relevant timings: the time from the beginning of acquisition to the start of 
bowel motion reduction and the duration of the reduced bowel motion period. 
 
ii. Reliability analysis 
In order to assess inter-rater variability, the time from the beginning of acquisition to the start of 
bowel motion reduction and the duration of effects obtained from each reader, for each slice of 
each animal, were loaded into SPSS® (SPSS Inc., NY, USA). In cases where bowel motion was 
maintained throughout the entire scan (classification always = 3), values of 90 min and 0 min were 
assigned to those variables, respectively. The single score intra-class correlation coefficient (ICC) 
assessing absolute agreement and using a two-way random effects model was then computed 
for each variable (Figure 3). 
 
iii. Consensual definition of motion reduction periods 
Both readers then defined in consensus time blocks and classifications for each single animal, 
taking into account information from both slices, and relevant timings were again calculated, i.e. 
the beginning and duration of periods with small bowel motion (Table 1). The time under a 
classification of 1 (absence of peristaltic motion) was also calculated. For the low- and high-dose 
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BUSC groups, the time from the injection of BUSC to the start of bowel motion reduction and the 
duration of BUSC effects were also computed, as well as their mean ± standard deviation. Mann-
Whitney testing at a significance level of 0.05 was used to evaluate differences between BUSC 
protocols on these timings. 
 
iv. Pre-processing 
Datasets were pre-processed and analyzed in MATLAB® (MathWorks Inc., Natick, MA). Transient 
global signal increases caused by variations in the breathing rate were corrected by normalizing 
each single image to the sum of all of its voxels’ intensity (Figure 4A). Subsequently, images were 
corrected for sporadic stripe artifacts by calculating their 2D Fourier transform and eliminating 
spurious signal that appeared at high-frequency regions of the k-space. Problematic regions of 
the k-space were first manually selected and then voxels in those regions were substituted by 0 
whenever their value was higher than 1.5 (and in one case, 1) times the standard deviation of its 
time-course. k-Space images were then 2D inverse-Fourier transformed to obtain the final 
corrected spatial images (Figure 4B). 
 
v. Motion maps and time-courses 
For a quantified motion estimation, the absolute differences between consecutive images were 
computed voxel-by-voxel. Those absolute differences were then summed for 10-11 min intervals 
throughout the acquisition and mapped voxelwise for identification of moving regions (Figure 5). 
Concurrently, the calculated absolute differences were thresholded at 20% of the highest 
difference for identification of significantly moving pixels at each time instant, and them summed 
inside those pixels for each animal (Figure 6). 
 
High-resolution abdominal images 
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After determining the most effective protocol for bowel motion reduction and to demonstrate its 
value in abdominal MRI, a T2-weighted Rapid Acquisition with Refocused Echoes (RARE) was 
acquired with an axial or coronal view from the abdomen of N = 2 mice before and approximately 
6.5 min after the administration of high-dose BUSC (5 mg/kg) (Figure 7, Figure S1 and Figure 
S2). In particular, TR/TE = 3500/25 ms, RARE factor = 8, in-plane resolution = 85 x 85 µm2, FOV 
= 26 x 26 mm2 (if axial slices) or 20 x 26 mm2 (if coronal slices), number of slices = 42, slice 
thickness = 0.3 mm, slice gap = 0.25 mm, respiratory triggering. Each scan lasted approximately 
49 min.  
Diffusion-weighted images were also acquired in N = 2 animals, before and 6.5 min after 
administration of high-dose BUSC (5 mg/kg) (Figure 8, Figure S3, Figure S4). A standard Stejskal-
Tanner sequence with EPI was used in both axial and coronal planes: TR/TE = 2000/13.6 ms, 10 
averages, 4 segments, double sampling, in-plane resolution = 150 x 150 µm2, FOV = 16 x 18 mm2 
(if axial slices) or 18 x 18 mm2 (if coronal slices), number of slices = 24 (if axial slices) or 22 (if 
coronal slices), slice thickness = 0.65 mm, slice gap = 0.2 mm, respiratory triggering, fat 
suppression, 14 directions of b = 1000 s/mm2 (powder averaged), 2 acquisitions of b = 0. Each 
scan lasted approximately 30 min. ADC maps were calculated for each acquisition using 
MATLAB® (MathWorks Inc., Natick, MA). ImageJ software (US National Institutes of Health) was 
used for manual drawing of regions of interest and calculation of averages and standard 
deviations (Figure 9). 
 
Results 
Concordance between readers. Figure 2 shows three examples of raw data with different degrees 
of peristaltic bowel motion, as classified by both readers. One of those three levels of motion was 
assigned by each reader to each time block of each animal slice’s time-course and relevant 
timings were extracted. The reliability analysis revealed a very high agreement between readers 
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for the time from beginning of acquisition to the start of bowel motion reduction (ICC(2,1) = 0.984)  
and for the duration of that reduced motion period ICC(2,1) = 0.951. Figure 3 displays two 
scatterplots with the measurements obtained from each reader, which in most cases closely 
approach the line of perfect agreement. 
Readers’ consensus on the effects of each protocol on bowel motility. Table 1 shows the time 
from the beginning of acquisition and from BUSC injection to the start of noticeable bowel motion 
reduction, together with the duration of those effects (calculated after merging blocks with a 
classification of 1 and 2), for each animal. An extra column with the time under a classification of 
1 was also included. Most of the mice in the food deprivation and saline groups never showed 
significant bowel motion reduction and, whenever a period of reduced bowel motion was detected, 
it never lasted longer than approximately 26 minutes. On the other hand, the animals under the 
low- or high-dose BUSC protocols showed sustained bowel motion reduction after injection. In 
particular, on average, the low-dose BUSC group showed noticeable bowel motion reduction after 
12.9 ± 9.6 minutes after injection with a duration of 46.8 ± 18.3 minutes. The time to start bowel 
motion reduction in the high-dose BUSC group was less variable in comparison with the low-dose 
group (8.5 ± 2.8 minutes), whereas the duration of the effect ranged the same values (40.8 ± 17.8 
minutes). However, Mann-Whitney testing revealed no significant differences between groups on 
these timings (P = 0.59 and P = 0.33, respectively). Moreover, half of the mice in the high-dose 
BUSC group showed mostly absent peristalsis, i.e. a classification of 1, while most of the animals 
(7 out of 8) in the low-dose BUSC only showed a reduced but residual peristalsis (a classification 
of 2). However, Mann-Whitney testing revealed no significant differences between groups on the 
time under a classification 1 (P = 0.28). 
Estimated motion maps and time-courses. To quantify the effects of each protocol on bowel 
motility, individual voxel-by-voxel motion maps and time-courses were also calculated. 
Consistently with the readers analysis, Figure 5 and Figure 6 show strongly reduced bowel motion 
in the high-dose BUSC group a few minutes after the injection, an effect noticeably more intense 
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in comparison with the other conditions’ groups. A maintained peristalsis is observed throughout 
the entire acquisition period in all animals from the food deprivation group and most of the animals 
from the saline group. Notably, an increase in motion caused by a change in bowel position and 
increase of bowel motility in the first five minutes after injection was consistent across all animals 
in both BUSC groups (Figure 6). This effect was also seen in most of the animals from the saline 
group. 
High-resolution abdominal images. The introduction of high-dose BUSC administration clearly 
improved image quality in terms of structural definition, organ detail and motion artifacts reduction. 
These effects are noticeable in both T2-weighted RARE and diffusion-weighted images, when 
comparing depiction of bowel walls and parenchymal organs: liver, pancreas, spleen and kidneys 
(Figure 7, Figure 8, Figure S1, Figure S2, Figure S3 and Figure S4). Regarding DWI, as expected, 
the BUSC effect is mostly noted in b = 1000 s/mm2 images, as these represent a powder average 
of 14 directions, acquired over nearly 30 minutes, highly susceptible to bowel motion artifacts 
during this time. ADC maps with examples of measurements in the liver are shown in Figure 9, 
with standard deviations slightly lower when using high-dose BUSC. 
 
Discussion  
Our study shows that BUSC is effective for bowel motion reduction in the mouse for an average 
duration of 40-45 min (Table 1, Figure 5 and Figure 6). Moreover, strongly reduced peristalsis 
seems to be best achieved when administering a single bolus of 5 mg/kg (high-dose BUSC 
protocol) in comparison to the 0.5 mg/kg dosage (low-dose BUSC protocol) (Table 1, Figure 6). 
The time interval from injection to start of bowel motion reduction should also be taken into 
account, which ranged between 5.2 min and 13.1 min in the high-dose BUSC group. 
These results reveal a longer duration of BUSC effects on mouse bowel peristalsis than previously 
described by Grimm et al. (4). Additionally, fasting, suggested by others(4,7) to have comparable 
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effects to BUSC, was not effective at all (Figure 5). These differences likely result from our motion 
quantification strategy involving both subjective and objective criteria. BUSC works as a blocker 
of muscarinic receptors for acetylcholine on smooth muscle cells in the gastrointestinal tract, 
reducing motility in a dose-dependent manner(13). This effect is evidently more intense and 
reliable than the motility reduction obtained with fasting.  
The high-resolution anatomical data acquired under the action of a high dose of BUSC reveals 
well-defined and detailed abdominal organs such as the bowel, kidneys, pancreas, spleen and 
liver, rather than the ill-defined organs observed in the data acquired without BUSC (Figure 7, 
Figure S1 and Figure S2). Also, when performing diffusion-weighted imaging, ADC maps or other 
quantifiable measurements are expected to be more accurately calculated in parenchymal organs 
with the reduction of motion-dependent artifacts(14,15). Our results seem to reflect this, with ADC 
measurements in the liver slightly more accurate using high-dose BUSC (Figure 9). Together, 
these results demonstrate the applicability of this protocol for diagnostic or 
segmentation/quantification processes in mouse abdominal MRI. 
As already established for humans(8), our findings reveal BUSC administration as valuable for 
reducing bowel motion artifacts in the mouse for MRI. An alternative method for achieving this 
might be the administration of glucagon, as this hormone is known to have a similar effect to 
BUSC in humans(16). Further studies might look into its use as an alternative for BUSC in the 
mouse. 
This work has its limitations. First, the relatively small number of animals used has limited the 
statistical evaluation of our results. Although trends were observed favoring the use of the high-
dose BUSC protocol when compared with the low-dose BUSC protocol for more reliable time to 
start and duration of effect, these were not statistically significant. Second, the administration of 
BUSC at room temperature (20 ºC) might have caused the short-duration increase in motion 
observed immediately following administration of both BUSC protocols and saline (Figure 6). This 
should be taken into account when considering performing repeated bolus protocols for long 
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periods of bowel motion reduction, as the motion caused by the repeated bolus injections could 
be detrimental to the data acquisitions. In this context, previously warming the solution to body 
temperature or using infusion protocols might prove beneficial. Lastly, the only route of 
administration used for BUSC testing was intraperitoneal due to the ease of catheter placement; 
however, other administration protocols using intravenous or intramuscular injections might 
provide different results(17).  
 
Conclusions  
BUSC administered in a single bolus at 5 mg/kg is effective for bowel motion reduction in the 
mouse for up to 45 min. These results are promising for future studies in the mouse abdomen 
requiring good anatomical definition, namely, for diagnosis or quantification purposes. 
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Figures and Tables 
 
 
Figure 1 – Study fluxogram. 
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Figure 2 – Classification of images according to the degree of motion. Three examples of 6 
consecutive images from the mouse abdomen acquired with a FLASH sequence in the coronal 
plane. Each row of 6 images represents a time period of approximately 1.5 minutes. Upper row: 
No noticeable peristalsis is observed (classification = 1). Middle row: Residual motion of bowel 
content without peristaltic motion, causing intensity changes (orange arrows) and susceptibility 
artifacts (red arrows) (classification = 2). Lower row: Peristaltic bowel motion. Notice the variability 
of luminal diameter in one bowel loop along this time period (yellow arrows) (classification = 3). 
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Figure 3 – Reliability analysis. (A) Time from the beginning of acquisition to the start of bowel 
motion reduction and (B) duration of small motion period measured by two readers for all animal 
slices (N = 64 slices) and respective measures of inter-rater agreement (ICC(2,1) = 0.984 and 
ICC(2,1) = 0.951). The calculated ICCs reveal a very high concordance between readers. 
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Group Animal 
Time to start motion 
reduction (min) 
Time under 1 and 2 
(min) Time 
under 1 
(min) 
After 
beginning of 
acquisition 
After 
BUSC 
injection 
After 
beginning of 
acquisition 
After 
BUSC 
injection 
Low-Dose 
BUSC 
1 15.5 5.5 74.5 
0.0 
2 41.2 31.2 41.2 
3 25.4 15.4 49.4 
4 18.1 8.1 49.8 
5 16.2 6.2 65.0 65.0 
6 33.3 23.3 33.3 
0.0 7 14.9 4.9 46.3 
8 19.0 9.0 14.9 
High-Dose 
BUSC 
9 0.0 7.1 52.0 34.9 29.2 
10 17.1 7.1 37.4 0.0 
11 17.7 7.7 29.5 29.5 
12 15.2 5.2 33.0 0.0 
13 18.1 8.1 61.8 61.8 
14 23.1 13.1 39.0 39.0 
15 22.5 12.5 18.4 
0.0 
16 17.1 7.1 72.9 
Food 
Deprivation 
17 
NR 
NA 
0.0 
NA 0.0 
18 
19 
20 
21 
22 19.3 24.4 
23 
NR 0.0 
24 
Saline 
25 
NR 0.0 
26 
27 26.3 19.3 
28 26.6 26.3 
29 
NR 0.0 
30 
31 
32 
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Table 1 – Relevant timings defined in consensus for each animal. Time from the beginning 
of acquisition and from BUSC bolus injection (performed after 10 min of acquisition) to the start 
of noticeable bowel motion reduction, as well as the duration of those effects, i.e. the time under 
a classification of 1 or 2. The time under a classification of 1 is also included. NR: No reduction. 
NA: Non-applicable. 
 
 
Figure 4 – Pre-processing of abdominal MR images. (A) Correction of transient global signal 
increases on 5 consecutive frames from a representative animal through power normalization, 
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where power represents the sum of signal intensities from all voxels in each slice frame. Upper 
row: Raw images with different powers. Lower row: Images with unitary power after normalization, 
revealing a significant reduction of global signal variations. (B) Correction of stripe artifacts on 2 
representative frames from a single animal through elimination of spurious signals at high-
frequency regions of the k-space. White boxes delineate regions prone to correction that were 
manually selected for that animal. 
 
 
Figure 5 – Individual motion maps. Voxel-by-voxel motion maps obtained for one representative 
slice of each animal, representing the calculated sum of the absolute differences between 
consecutive images for 10-11 min intervals throughout the acquisition. Dark blue areas represent 
regions without significant bowel motility. A raw image from the slice is presented on the left of 
each map for anatomical region definition. Bowel motion was strongly reduced in the high-dose 
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BUSC group a few minutes after the injection, which occurred at 10 min of acquisition, and was 
noticeably reduced in comparison to the other conditions’ groups. The food deprivation group 
reveals a maintained peristalsis in all animals throughout the entire acquisition period. Similar 
findings are observed in the saline group, with maintained bowel motion in most animals scanned. 
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Figure 6 – Individual motion time-courses. Estimated motion time-courses obtained from both 
slices of each animal, depicting the sum of absolute differences between consecutive images 
from significantly moving pixels, i.e. pixels whose absolute difference was higher than 20% of the 
highest difference, at each time instant. Yellow areas represent time intervals with reduced but 
residual peristalsis (classification = 2) and orange areas represent time intervals where peristalsis 
was strongly reduced (classification = 1), both defined in consensus by the two readers. Blue lines 
indicate i.p. injection of a BUSC bolus whereas gray lines represent i.p. injection of saline. 
 
 
Figure 7 – T2 RARE images of the abdomen before and after high-dose BUSC injection. 
Representative (A) axial and (B) coronal images of the mouse abdomen acquired without BUSC 
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and 6.5 min after BUSC i.p. injection. A sharper definition of the bowel (yellow arrows) is 
consistently observed in the post-injection images. Parenchymal organs are also more clearly 
defined and detailed with BUSC administration, as observed in the kidneys (green arrows), the 
spleen (blue arrows) and the liver (red arrows). 
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Figure 8 – Diffusion-weighted images of the abdomen before and after administration of 
high-dose BUSC, with corresponding ADC maps. Representative (A) axial and (B) coronal 
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images of the mouse abdomen, demonstrating the effectiveness of BUSC in reducing motion 
artifacts. This effect is clearer in the b = 1000 s/mm2 images, as these represent a powder average 
of 14 directions. The liver (red arrows), kidneys (green arrows) and bowels (yellow arrows) are 
notably more detailed and better defined after administrating high-dose BUSC. 
 
 
Figure 9 – ADC maps produced from acquisitions with and without high-dose BUSC 
administration. Coronal and axial slices of two animals, with equally positioned regions of 
interest in the liver parenchyma, demonstrating a slightly lower standard deviation of ADC 
measurements after BUSC administration. 
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Figure S1 – Axial images of the abdomen after BUSC injection. T2-weighted images of a 
mouse abdomen acquired 6.5 min after BUSC i.p. injection, from caudal to cranial. 
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Figure S2 – Coronal images of the abdomen after BUSC injection. T2-weighted images of a 
mouse abdomen acquired 6.5 min after BUSC i.p. injection, from dorsal to ventral. Slices without 
any body signal contribution are not displayed. 
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Figure S3 – Axial images of the abdomen after BUSC injection. DWI (b1000) images of a 
mouse abdomen acquired 6.5 min after BUSC i.p. injection, from cranial to caudal. 
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Figure S4 – Coronal images of the abdomen after BUSC injection. DWI (b1000) images of a 
mouse abdomen acquired 6.5 min after BUSC i.p. injection, from dorsal to ventral. 
 
 
  
 
